We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.59B
AUM Growth
+$680M
Cap. Flow
+$262M
Cap. Flow %
3.98%
Top 10 Hldgs %
67.98%
Holding
142
New
14
Increased
46
Reduced
57
Closed
13

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$47.5M
2
MSFT icon
Microsoft
MSFT
+$42.5M
3
TMO icon
Thermo Fisher Scientific
TMO
+$37.3M
4
ECL icon
Ecolab
ECL
+$36.9M
5
SBUX icon
Starbucks
SBUX
+$33.8M

Top Sells

Rank Stock Value
1
HDB icon
HDFC Bank
HDB
+$101M
2
PM icon
Philip Morris
PM
+$21.2M
3
META icon
Meta Platforms (Facebook)
META
+$11.4M
4
CELG
Celgene Corp
CELG
+$9.78M
5
MRK icon
Merck
MRK
+$8.94M

Sector Composition

Rank Sector Weight
1 Financials 26.2%
2 Healthcare 18.75%
3 Consumer Discretionary 17.75%
4 Communication Services 14.57%
5 Materials 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
26
Coca-Cola
KO
$383B
$36.2M 0.55%
806,708
+520,720
+182% +$23M
AGN
27
DELISTED
Allergan plc
AGN
$24M 0.36%
98,790
-9,806
-9% -$2.3M
CELG
28
DELISTED
Celgene Corp
CELG
$23.9M 0.36%
184,063
-79,796
-30% -$9.78M
CLVS
29
DELISTED
Clovis Oncology, Inc.
CLVS
$20.9M 0.32%
223,560
-85,609
-28% -$5.24M
AMGN icon
30
Amgen
AMGN
$209B
$19.8M 0.3%
115,228
-39,526
-26% -$6.43M
PFE icon
31
Pfizer
PFE
$143B
$19.2M 0.29%
600,993
-198,688
-25% -$6.27M
BIIB icon
32
Biogen
BIIB
$30.9B
$17.7M 0.27%
65,375
-18,758
-22% -$4.96M
JAZZ icon
33
Jazz Pharmaceuticals
JAZZ
$16.1B
$16.3M 0.25%
105,048
+6,583
+7% +$1.01M
CNC icon
34
Centene
CNC
$30.5B
$16.3M 0.25%
407,088
-98,252
-19% -$3.71M
CI icon
35
Cigna
CI
$78.4B
$16.2M 0.25%
96,878
-24,850
-20% -$3.99M
INCY icon
36
Incyte
INCY
$25.4B
$15.6M 0.24%
123,724
-13,844
-10% -$1.76M
BMY icon
37
Bristol-Myers Squibb
BMY
$129B
$14.9M 0.23%
+267,012
New +$14.5M
ALXN
38
DELISTED
Alexion Pharmaceuticals
ALXN
$13.8M 0.21%
113,427
+74,676
+193% +$8.69M
MRK icon
39
Merck
MRK
$322B
$13.3M 0.2%
218,056
-146,858
-40% -$8.94M
ABBV icon
40
AbbVie
ABBV
$465B
$12.4M 0.19%
171,047
+90,222
+112% +$6.07M
GOOGL icon
41
Alphabet (Google) Class A
GOOGL
$4.12T
$12.1M 0.18%
261,080
– –
SHPG
42
DELISTED
Shire pic
SHPG
$11.9M 0.18%
71,845
-42,955
-37% -$7.51M
HCA icon
43
HCA Healthcare
HCA
$90.6B
$11.9M 0.18%
136,152
-12,733
-9% -$1.08M
EW icon
44
Edwards Lifesciences
EW
$49.4B
$11.4M 0.17%
288,786
-28,398
-9% -$1.04M
NKE icon
45
Nike
NKE
$64.1B
$11.2M 0.17%
190,523
-6,969
-4% -$376K
LLY icon
46
Eli Lilly
LLY
$1.08T
$10.7M 0.16%
130,484
-13,511
-9% -$1.1M
GKOS icon
47
Glaukos
GKOS
$9.49B
$10.7M 0.16%
257,831
-102,977
-29% -$4.44M
PRTK
48
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$10.6M 0.16%
439,400
+359,400
+449% +$7.95M
BSX icon
49
Boston Scientific
BSX
$68.4B
$10.6M 0.16%
+381,472
New +$10.1M
BMRN icon
50
BioMarin Pharmaceuticals
BMRN
$11.9B
$9.43M 0.14%
103,781
-60,704
-37% -$5.52M
1
2
3 4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2017 Portfolio in Review

As of Q2 2017, C WorldWide Group held 142 positions worth $6.59B, up 12% from $5.91B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

C WorldWide Group deployed $262M of net new capital in Q2 2017, opening 14 new positions and adding to 46 existing holdings. Its largest new stake was Bristol-Myers Squibb: 267,012 shares worth $14.9M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was HDFC Bank, an estimated $101M trimmed.

  • C WorldWide Group's largest Q2 2017 buy was Bristol-Myers Squibb: 267,012 shares worth $14.9M.
  • C WorldWide Group added most to Visa in Q2 2017, an estimated $47.5M increase.
  • C WorldWide Group's biggest Q2 2017 reduction was HDFC Bank, cutting an estimated $101M.
  • C WorldWide Group fully exited Novadaq Technologies Inc. in Q2 2017, selling an estimated $3.86M.
  • C WorldWide Group's ten largest holdings make up 68% of its $6.59B portfolio in Q2 2017.
  • C WorldWide Group opened 14 new positions and closed 13 in Q2 2017.
  • C WorldWide Group's portfolio value rose 12% quarter-over-quarter to $6.59B.

Based on C WorldWide Group's 13F filing for Q2 2017, filed 2 Aug 2017.